6. rijnierse.vbhc event prize - presentation amgen (def)
Periodic Bi-Weekly OIS-Process Development 07-MAY-15
Amgen Presentation at VBHC Prize 2015 event
Treating Cancer with T Cell- Engaging Antibodies Flavius Martin M.D. Vice President Research, Amgen Inc.
The Academic Contribution to Drug Development Roger M. Perlmutter Executive Vice President, Research and Development.
Flow Data Analysis Challenges Deck from Amgen Attendees
The Academic Contribution to Drug Development
Julie Matthew January 22, 2010 MIT LGO Alumni Web Seminar
A Qualitative Decision Making Tool to Aid in Defining the Number of Lots for a Process Validation Campaign Leslie Sidor — Amgen Inc. 2012 Midwest Biopharmaceutical.
